Dr Reddy’s buys GSK US penicillin unit
PTI | , New Delhi
Press Trust of India Mar 30, 2011 10:03 PM IST
Dr Reddy’s Laboratories on Wednesday announced the acquisition of GlaxoSmithKline’s US penicillin manufacturing facility and the rights to the Augmentin and Amoxil brands in the US for an undisclosed sum.
Dr Reddy’s Laboratories on Wednesday announced the acquisition of GlaxoSmithKline’s US penicillin manufacturing facility and the rights to the Augmentin and Amoxil brands in the US for an undisclosed sum. “GSK will retain the existing rights of these brands outside the US,” Dr Reddy’s said in a filing to the BSE.
The acquisition of the oral pencillin manufacturing facility in Bristol and product portfolio was completed on Tuesday and is pursuant to the agreement signed by the companies on November 23, 2010.
Hindustan Times - your fastest source for breaking news! Read now.
Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away!- Login Now!
Stay informed on Business News along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs
Stay informed on Business News along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs
Share this article